Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 47 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Neurological Disorders and Stroke
Grant: R21/R33NS096032
HHS | NIH | National Institute of Neurological Disorders and Stroke
Grant: R35NS116846
HHS | NIH | National Institute of Neurological Disorders and Stroke
Grant: DP1NS096898
HHS | NIH | National Institute of General Medical Sciences
Grant: R01GM097455
NINDS NIH HHS
Grant: R01 NS101134
NINDS NIH HHS
Grant: R21 NS096032
NIGMS NIH HHS
Grant: R01 GM145886
NINDS NIH HHS
Grant: R21 NS123770
NINDS NIH HHS
Grant: R33 NS096032
NINDS NIH HHS
Grant: UG3 NS116921
NINDS NIH HHS
Grant: RF1 NS130702
NIA NIH HHS
Grant: R21 AG075656
NINDS NIH HHS
Grant: UH3 NS116921
NIDA NIH HHS
Grant: R03 DA033977
National Institutes of Health
Grant: 1R21NS123770-01
Role of Transglutaminase 2 in Synucleinopathies
National Institutes of Health
Grant: 4UH3NS116921-02
RNA Targeted Drug Discovery and Development for Parkinson Disease
National Institutes of Health
Grant: 5R01GM097455-06
Sequence-based Design of Small Molecules Targeting RNA
National Institutes of Health
Grant: 4R33NS096032-02
Developing Novel RNA-Based Therapeutics for Parkinson's Disease
National Institutes of Health
Grant: 5DP1NS096898-02
Using a disease-affected cell to synthesize its own drug
National Institutes of Health
Grant: 1RF1NS130702-01
PME-1: Pathogenetic Role and Therapeutic Opportunity in Neurodegenerative Mixed Proteinopathies
National Institutes of Health
Grant: 1R35NS116846-01
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology
National Institutes of Health
Grant: 5R01NS101134-03
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies
National Institutes of Health
Grant: 1R21AG075656-01A1
Alzheimer’s Disease Protection by Reduced Adenylyl Cyclase Type 5
FWCI
7.62
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals